pioglitazone has been researched along with Infant, Small for Gestational Age in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lian, QX | 1 |
Deng, HZ | 1 |
Chen, KY | 1 |
Deng, H | 1 |
1 other study available for pioglitazone and Infant, Small for Gestational Age
Article | Year |
---|---|
Role of Peroxisome Proliferator-Activated Receptor (PPARĪ³) in Metabolic Disorders in SGA with Catch-Up Growth.
Topics: Adult; Animals; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Male; Metabolic | 2018 |